🇺🇸 FDA
Patent

US 9803022

Mesothelin domain-specific monoclonal antibodies and use thereof

granted A61KA61K2039/505A61K39/395

Quick answer

US patent 9803022 (Mesothelin domain-specific monoclonal antibodies and use thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K2039/505, A61K39/395, A61K47/6829, A61K47/6849